Eton Pharmaceuticals (ETON) Invested Capital (2020 - 2025)

Eton Pharmaceuticals (ETON) has 6 years of Invested Capital data on file, last reported at $8.8 million in Q4 2025.

• For the quarter ending Q4 2025, Invested Capital changed N/A year-over-year to $8.8 million; the trailing twelve-month figure through Dec 2025 stood at $14.3 million (up 3.85% YoY), and the FY2025 full-year result was $8.8 million, changed N/A from the prior year.
• Invested Capital advanced to $8.8 million in Q4 2025, from $2.8 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $8.8 million in Q4 2025 to a low of $708000.0 in Q3 2022.
• A 5-year average of $3.8 million and a median of $3.5 million in 2024 frame the typical range for Invested Capital.
• Peak annual rise in Invested Capital reached 783.18% in 2022, while the deepest fall reached 85.24% in 2022.
• Tracing ETON's Invested Capital over 5 years: stood at $7.0 million in 2021, then sank by 85.24% to $1.0 million in 2022, then jumped by 420.81% to $5.4 million in 2023, then retreated by 23.33% to $4.1 million in 2024, then jumped by 113.07% to $8.8 million in 2025.
• Business Quant data shows ETON's Invested Capital at $8.8 million in Q4 2025, $2.8 million in Q3 2025, and $2.8 million in Q2 2025.